137 related articles for article (PubMed ID: 31560457)
1. Stability of αB-crystallin gene expression in canine mammary gland neoplasms. Should it be considered as circulating tumor cell genetic marker?
Chmielewska-Krzesińska M; Jakimiuk A; Wąsowicz K
Pol J Vet Sci; 2019 Sep; 22(3):523-529. PubMed ID: 31560457
[TBL] [Abstract][Full Text] [Related]
2. Alpha basic crystallin expression in canine mammary tumors.
Guvenc T; Gulbahar MY; Yarim M; Kabak YB; Karayigit O; Sozmen M
J Vet Sci; 2012 Mar; 13(1):39-42. PubMed ID: 22437534
[TBL] [Abstract][Full Text] [Related]
3. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
[TBL] [Abstract][Full Text] [Related]
4. Loss of p27 expression in canine mammary tumors and their metastases.
Klopfleisch R; Schütze M; Gruber AD
Res Vet Sci; 2010 Apr; 88(2):300-3. PubMed ID: 19748645
[TBL] [Abstract][Full Text] [Related]
5. The relationship between basal and luminal cytokeratins with histopathologic characteristics of canine mammary gland cancer.
Eivani D; Mortazavi P
Pol J Vet Sci; 2016; 19(2):261-9. PubMed ID: 27487499
[TBL] [Abstract][Full Text] [Related]
6. Reduced canine BRCA2 expression levels in mammary gland tumors.
Yoshikawa Y; Morimatsu M; Ochiai K; Ishiguro-Oonuma T; Wada S; Orino K; Watanabe K
BMC Vet Res; 2015 Jul; 11():159. PubMed ID: 26202431
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of alphaB-crystallin and Hsp27-1 in anaplastic thyroid carcinomas because of tumor-specific alphaB-crystallin gene (CRYAB) silencing.
Mineva I; Gartner W; Hauser P; Kainz A; Löffler M; Wolf G; Oberbauer R; Weissel M; Wagner L
Cell Stress Chaperones; 2005; 10(3):171-84. PubMed ID: 16184762
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical and quantitative RT-PCR methods to assess RANK expression in normal and neoplastic canine mammary gland.
Sánchez-Céspedes R; Millan Y; Guil-Luna S; García-Macías J; Maniscalco L; Iussich S; De Maria R; M de Las Mulas J
J Vet Diagn Invest; 2018 Jan; 30(1):155-160. PubMed ID: 29020879
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and tumour suppressor function analysis of canine REIC/Dkk-3 in mammary gland tumours.
Ochiai K; Watanabe M; Azakami D; Michishita M; Yoshikawa Y; Udagawa C; Metheenukul P; Chahomchuen T; Aoki H; Kumon H; Morimatsu M; Omi T
Vet J; 2013 Sep; 197(3):769-75. PubMed ID: 23732075
[TBL] [Abstract][Full Text] [Related]
10. Alteration of somatostatin receptor 2 expression in canine mammary gland tumor.
Sakai K; Yonezawa T; Yamawaki H; Oyamada T
J Vet Med Sci; 2015 Oct; 77(10):1319-22. PubMed ID: 25985817
[TBL] [Abstract][Full Text] [Related]
11. Advancing canine mammary tumor diagnostics: Unraveling the diagnostic potential of Cytokeratin 19 through droplet digital PCR analysis.
Tanvetthayanont P; Yata T; Boonnil J; Temisak S; Ponglowhapan S
Theriogenology; 2024 Mar; 217():127-135. PubMed ID: 38271766
[TBL] [Abstract][Full Text] [Related]
12. The relationship between clinicopathological features and expression of epithelial and mesenchymal markers in spontaneous canine mammary gland tumors.
Yoshida K; Yoshida S; Choisunirachon N; Saito T; Matsumoto K; Saeki K; Mochizuki M; Nishimura R; Sasaki N; Nakagawa T
J Vet Med Sci; 2014 Oct; 76(10):1321-7. PubMed ID: 24931646
[TBL] [Abstract][Full Text] [Related]
13. Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors.
Spoerri M; Guscetti F; Hartnack S; Boos A; Oei C; Balogh O; Nowaczyk RM; Michel E; Reichler IM; Kowalewski MP
BMC Vet Res; 2015 Sep; 11():235. PubMed ID: 26370564
[TBL] [Abstract][Full Text] [Related]
14. Expression and significance of CHIP in canine mammary gland tumors.
Wang H; Yang X; Jin Y; Pei S; Zhang D; Ma W; Huang J; Qiu H; Zhang X; Jiang Q; Sun W; Zhang H; Lin D
J Vet Med Sci; 2015 Nov; 77(11):1465-71. PubMed ID: 26156079
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of FOXP3 expression in canine mammary gland tumours.
Oh SY; Ryu HH; Yoo DY; Hwang IK; Kweon OK; Kim WH
Vet Comp Oncol; 2014 Mar; 12(1):20-8. PubMed ID: 22541038
[TBL] [Abstract][Full Text] [Related]
16. Expression and significance of PTEN in canine mammary gland tumours.
Qiu C; Lin D; Wang J; Wang L
Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
[TBL] [Abstract][Full Text] [Related]
17. p63: a novel myoepithelial cell marker in canine mammary tissues.
Gama A; Alves A; Gartner F; Schmitt F
Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
[TBL] [Abstract][Full Text] [Related]
18. Lens epithelial cells derived from alphaB-crystallin knockout mice demonstrate hyperproliferation and genomic instability.
Andley UP; Song Z; Wawrousek EF; Brady JP; Bassnett S; Fleming TP
FASEB J; 2001 Jan; 15(1):221-229. PubMed ID: 11149910
[TBL] [Abstract][Full Text] [Related]
19. AlphaB-crystallin regulates intermediate filament organization in situ.
Head MW; Hurwitz L; Kegel K; Goldman JE
Neuroreport; 2000 Feb; 11(2):361-5. PubMed ID: 10674487
[TBL] [Abstract][Full Text] [Related]
20. Expression of stratified squamous epithelia-type cytokeratin by canine mammary epithelial cells during tumorigenesis: type I (acidic) 57 kilodalton cytokeratin could be a molecular marker for malignant transformation of mammary epithelial cells.
Arai K; Kaneko S; Naoi M; Suzuki K; Maruo K; Uehara K
J Vet Med Sci; 1994 Feb; 56(1):51-8. PubMed ID: 7515697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
